Fujifilm Demonstrates Interlock Trocar, an Innovative Tandem Motion Visualization Device

VALHALLA, N.Y., March 28, 2019 /PRNewswire/ -- FUJIFILM New Development, U.S.A., Inc., an innovative provider of minimally invasive surgical solutions, is introducing its new Fujifilm InterLock Trocar, a novel tandem motion visualization device that allows a surgeon to control both a laparoscope and a hand instrument at the same time and with one hand.

"We're excited to demonstrate the Fujifilm InterLock Trocar which was designed to make performing surgeries easier and more efficient for surgeons and less invasive for patients," says Stephen Mariano, Vice President and General Manager, FUJIFILM New Development, U.S.A., Inc. "The technology represents a true paradigm shift in minimally invasive surgery. With just one small incision surgeons now have the ability to manipulate simultaneously both a laparoscope and a hand instrument with one hand. Busy ambulatory surgical centers and hospital ORs will appreciate the fact that with InterLock Trocar no additional clinician is required to control visualization while a surgeon is operating."

Fujifilm's InterLock Trocar is uniquely designed to provide surgical access through a single incision for both a 5mm hand instrument and the Fujifilm Ultra-Slim "Chip on the Tip" HD Video Laparoscope. The technology allows the surgeon full control of the scope throughout the procedure by directly controlling the hand instrument. Tandem motion of the hand instrument and the Fujifilm scope is achieved through a unique coupling mechanism within the InterLock Trocar.

Additional features include an integrated lens cleaning function, which allows the lens to be cleaned and restores brilliant image quality without removing the scope from the trocar—saving time and reducing the need for repositioning. The InterLock Trocar was also designed to adjust and maintain the image horizon regardless of hand instrument positioning and orientation. Finally, Fujifilm's advanced Ultra-Slim video laparoscope system delivers exceptional image resolution, excellent color fidelity, and sharp display quality—all while featuring a comfortable, ergonomic design. The device is compatible with most common 5mm hand instruments on the market.

Fujifilm's InterLock Trocar has received 510k clearance from the FDA, and will be commercially available in the United States later this year.

See this technology in action at the Fujifilm booth #629 at the Society of American Gastrointestinal and Endoscopic Surgeons 2019 Annual Meeting (SAGES 2019) from April 3-6 at the Baltimore Convention Center in Baltimore, Maryland.

About Fujifilm

FUJIFILM New Development, U.S.A., Inc., is an innovative provider of minimally invasive surgical systems designed to meet the needs of surgeons across the clinical spectrum today and well into the future. From an unparalleled ultra-slim video laparoscope system to a full high definition surgical visualization system, Fujifilm's product portfolio is revolutionizing the conventional surgical endoscopic procedure and raising the standard of patient care.

FUJIFILM Holdings Corporation, Tokyo, Japan brings cutting-edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

SOURCE FUJIFILM New Development, U.S.A., Inc.

Related Links

https://www.fujifilmmis.com